Document is current
Any future updates will be listed below
-
Authors
Castaño-Rodríguez, Natalia
Popple, Georgia L.
Porras-Hurtado, Gloria Liliana
Cardona-Deazza, José Luis
Montoya-Martinez, Juan José
Cadavid-Velez, Antonio Javier
Toro-Hidalgo, Héctor William
Cobo-Alvarado, Alba Ruth
del Socorro Hincapié-Rincón, Ofelia
Riordan, Stephen M.
Kaakoush, Nadeem O. https://orcid.org/0000-0003-4017-1077
-
Funding
Funding for this research was provided by:
Cancer Institute NSW (15/CDF/1-11)
National Health and Medical Research Council (APP1111461)
Cancer Australia (1129488)
- License Information
-
More Information
Article History
Received: 1 October 2018
Accepted: 28 November 2018
First Online: 7 December 2018
Ethics approval and consent to participate
: Esophageal adenocarcinoma cohort samples: Ethics approval was obtained from the South Eastern Sydney Local Health District Human Research Ethics Committee (HREC 13/375 and HREC 16/020). Gastric adenocarcinoma cohort samples: Ethics approvals have been gained from Comfamilar Risaralda Hospital (Acta 5140) and the University of New South Wales (UNSW) (HREC 16010) human research ethics committees.All subjects recruited to the study signed a written informed consent, and all experiments were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
